vs
FIRST HAWAIIAN, INC.（FHB）与GLAUKOS Corp（GKOS）财务数据对比。点击上方公司名可切换其他公司
FIRST HAWAIIAN, INC.的季度营收约是GLAUKOS Corp的1.5倍（$220.3M vs $143.1M），FIRST HAWAIIAN, INC.净利率更高（30.8% vs -93.4%，领先124.1%），过去两年GLAUKOS Corp的营收复合增速更高（29.3% vs 3.8%）
第一夏威夷公司是总部位于夏威夷檀香山的银行控股企业，核心子公司第一夏威夷银行成立于1858年，是夏威夷历史最悠久、规模最大的金融机构，总部设在檀香山第一夏威夷中心。该行在夏威夷设有57家分支机构，关岛有3家，塞班岛有1家，为个人及商业客户提供存款、贷款、财富管理、保险、私人银行等多元金融服务。
Glaukos Corp是一家专注于眼科领域的医疗科技企业，开发并商业化用于治疗青光眼、角膜疾病等眼部病症的微创手术器械、处方药物及消费级产品，主要市场覆盖北美、欧洲及亚太地区，为全球医院、眼科诊所及患者提供服务。
FHB vs GKOS — 直观对比
营收规模更大
FHB
是对方的1.5倍
$143.1M
净利率更高
FHB
高出124.1%
-93.4%
两年增速更快
GKOS
近两年复合增速
3.8%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $220.3M | $143.1M |
| 净利润 | $67.8M | $-133.7M |
| 毛利率 | — | -1.1% |
| 营业利润率 | — | -97.7% |
| 净利率 | 30.8% | -93.4% |
| 营收同比 | — | 35.7% |
| 净利润同比 | 14.4% | -298.0% |
| 每股收益（稀释后） | $0.55 | $-2.34 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FHBGKOS
| Q1 26 | $220.3M | — | ||
| Q4 25 | $225.9M | $143.1M | ||
| Q3 25 | $226.4M | $133.5M | ||
| Q2 25 | $217.5M | $124.1M | ||
| Q1 25 | $211.0M | $106.7M | ||
| Q4 24 | $188.1M | $105.5M | ||
| Q3 24 | $210.0M | $96.7M | ||
| Q2 24 | $204.6M | $95.7M |
净利润FHBGKOS
| Q1 26 | $67.8M | — | ||
| Q4 25 | $69.9M | $-133.7M | ||
| Q3 25 | $73.8M | $-16.2M | ||
| Q2 25 | $73.2M | $-19.7M | ||
| Q1 25 | $59.2M | $-18.1M | ||
| Q4 24 | $52.5M | $-33.6M | ||
| Q3 24 | $61.5M | $-21.4M | ||
| Q2 24 | $61.9M | $-50.5M |
毛利率FHBGKOS
| Q1 26 | — | — | ||
| Q4 25 | — | -1.1% | ||
| Q3 25 | — | 78.4% | ||
| Q2 25 | — | 78.3% | ||
| Q1 25 | — | 77.2% | ||
| Q4 24 | — | 72.9% | ||
| Q3 24 | — | 76.6% | ||
| Q2 24 | — | 76.4% |
营业利润率FHBGKOS
| Q1 26 | — | — | ||
| Q4 25 | 41.2% | -97.7% | ||
| Q3 25 | 42.5% | -12.3% | ||
| Q2 25 | 40.5% | -18.3% | ||
| Q1 25 | 36.5% | -19.4% | ||
| Q4 24 | 34.4% | -27.2% | ||
| Q3 24 | 36.4% | -25.5% | ||
| Q2 24 | 39.5% | -31.3% |
净利率FHBGKOS
| Q1 26 | 30.8% | — | ||
| Q4 25 | 31.0% | -93.4% | ||
| Q3 25 | 32.6% | -12.2% | ||
| Q2 25 | 33.7% | -15.8% | ||
| Q1 25 | 28.1% | -17.0% | ||
| Q4 24 | 27.9% | -31.8% | ||
| Q3 24 | 29.3% | -22.1% | ||
| Q2 24 | 30.3% | -52.8% |
每股收益（稀释后）FHBGKOS
| Q1 26 | $0.55 | — | ||
| Q4 25 | $0.56 | $-2.34 | ||
| Q3 25 | $0.59 | $-0.28 | ||
| Q2 25 | $0.58 | $-0.34 | ||
| Q1 25 | $0.47 | $-0.32 | ||
| Q4 24 | $0.41 | $-0.56 | ||
| Q3 24 | $0.48 | $-0.39 | ||
| Q2 24 | $0.48 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $90.8M |
| 总债务越低越好 | $0 | — |
| 股东权益账面价值 | $2.8B | $656.2M |
| 总资产 | $24.3B | $893.5M |
| 负债/权益比越低杠杆越低 | 0.00× | — |
8季度趋势，按日历期对齐
现金及短期投资FHBGKOS
| Q1 26 | — | — | ||
| Q4 25 | — | $90.8M | ||
| Q3 25 | — | $98.2M | ||
| Q2 25 | — | $100.8M | ||
| Q1 25 | — | $114.3M | ||
| Q4 24 | — | $169.6M | ||
| Q3 24 | — | $100.1M | ||
| Q2 24 | — | $68.1M |
总债务FHBGKOS
| Q1 26 | $0 | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益FHBGKOS
| Q1 26 | $2.8B | — | ||
| Q4 25 | $2.8B | $656.2M | ||
| Q3 25 | $2.7B | $769.5M | ||
| Q2 25 | $2.7B | $765.1M | ||
| Q1 25 | $2.6B | $764.0M | ||
| Q4 24 | $2.6B | $766.9M | ||
| Q3 24 | $2.6B | $668.5M | ||
| Q2 24 | $2.6B | $665.2M |
总资产FHBGKOS
| Q1 26 | $24.3B | — | ||
| Q4 25 | $24.0B | $893.5M | ||
| Q3 25 | $24.1B | $999.4M | ||
| Q2 25 | $23.8B | $987.0M | ||
| Q1 25 | $23.7B | $966.2M | ||
| Q4 24 | $23.8B | $974.8M | ||
| Q3 24 | $23.8B | $926.5M | ||
| Q2 24 | $24.0B | $919.7M |
负债/权益比FHBGKOS
| Q1 26 | 0.00× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $6.8M |
| 自由现金流经营现金流 - 资本支出 | — | $3.9M |
| 自由现金流率自由现金流/营收 | — | 2.7% |
| 资本支出强度资本支出/营收 | — | 2.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-22.5M |
8季度趋势，按日历期对齐
经营现金流FHBGKOS
| Q1 26 | — | — | ||
| Q4 25 | $335.1M | $6.8M | ||
| Q3 25 | $57.1M | $-10.1M | ||
| Q2 25 | $136.4M | $7.0M | ||
| Q1 25 | $36.7M | $-18.5M | ||
| Q4 24 | $317.5M | $507.0K | ||
| Q3 24 | $58.9M | $-9.6M | ||
| Q2 24 | $78.2M | $-18.4M |
自由现金流FHBGKOS
| Q1 26 | — | — | ||
| Q4 25 | $303.3M | $3.9M | ||
| Q3 25 | $49.5M | $-11.7M | ||
| Q2 25 | $125.2M | $5.8M | ||
| Q1 25 | $28.6M | $-20.5M | ||
| Q4 24 | $288.7M | $-1.2M | ||
| Q3 24 | $52.3M | $-11.0M | ||
| Q2 24 | $72.2M | $-20.5M |
自由现金流率FHBGKOS
| Q1 26 | — | — | ||
| Q4 25 | 134.3% | 2.7% | ||
| Q3 25 | 21.9% | -8.8% | ||
| Q2 25 | 57.5% | 4.7% | ||
| Q1 25 | 13.6% | -19.2% | ||
| Q4 24 | 153.5% | -1.2% | ||
| Q3 24 | 24.9% | -11.4% | ||
| Q2 24 | 35.3% | -21.4% |
资本支出强度FHBGKOS
| Q1 26 | — | — | ||
| Q4 25 | 14.1% | 2.0% | ||
| Q3 25 | 3.3% | 1.2% | ||
| Q2 25 | 5.2% | 0.9% | ||
| Q1 25 | 3.8% | 1.8% | ||
| Q4 24 | 15.3% | 1.6% | ||
| Q3 24 | 3.1% | 1.5% | ||
| Q2 24 | 2.9% | 2.2% |
现金转化率FHBGKOS
| Q1 26 | — | — | ||
| Q4 25 | 4.79× | — | ||
| Q3 25 | 0.77× | — | ||
| Q2 25 | 1.86× | — | ||
| Q1 25 | 0.62× | — | ||
| Q4 24 | 6.05× | — | ||
| Q3 24 | 0.96× | — | ||
| Q2 24 | 1.26× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FHB
| Net Interest Income | $167.5M | 76% |
| Noninterest Income | $52.8M | 24% |
GKOS
| Glaucoma | $86.4M | 60% |
| Other | $35.1M | 25% |
| Corneal Health | $21.6M | 15% |
